CTOs on the Move

theator

www.theator.io

 
Built for surgeons by surgeons, Theator is pioneering the Surgical Intelligence Revolution, empowering surgeons everywhere to raise their expertise to the highest possible level.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

theator raised $15.5M on 02/09/2021

Similar Companies

Autonomic Technologies

Welcome. Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company`s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache. The ATI Neurostimulation System was voted #2 among the Cleveland Clinic’s top 10 medical innovations for 2013, and Autonomic Technologies was named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world.

Dycem USA

Dycem USA is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pilot Health Saving Accounts

Pilot Health Saving Accounts is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Centric Health

Centric Health`s vision is to be Canada`s premier healthcare company, providing innovative solutions centered on patients and healthcare professionals.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.